|
|
 |
|
Viewing report
|
|
|
|
Stem Cell Companies: The 28 Leaders
Centient Consulting, Inc, Sep 2006, Pages: 83
We have just completed our most in-dept report report to date - Stem Cell Companies: The 28 Leaders. This much-expanded version of our most popular report now includes many additional details on each company, as well as insights on the industry's driving factors.
Our senior analysts, Frank H. Eeckman, MD, PhD, and Richard Daverman, PhD, explore the trends and players that make up this emreging industry. We look at each company in detail, including charts and graphs of company performance, investors, clinical trials, collaborations, target diseases and technologies.
Human embryonic stem cells were first isolated in the late 1990s and by early 2000 several companies entered the market attempting to commercialize these discoveries. It quickly led to a new wave in biotechnology.
As with any burgeoning market, many companies were anxious to participate, announcing stem cell programs of one sort or another. Market research firms created lists of “stem cell companies” that numbered as high as 80. But many companies on these lists were hoping to catch the wave and gain additional funding or market awareness and were actually focused elsewhere. Complicating matters is the controversy regarding the source of human embryonic stem cells (hESC). Several of these companies have left the field and no longer mention stem cells. Others, including some of the most talked about true-blue stem cell high-flyers, have gone out of business or restructured their operations.
That is the nature of biotech business, and no one should infer from this that stem cells are a dead end. As a matter of fact, stem cell researchers and companies are remarkably successful, considering that it often takes decades before a technology matures enough that it is ready for the market place. One only needs to think of the 30 years it took monoclonal antibodies to go from the hot new technology stage to the commercial blockbusters they are today.
Stem Cell Technology There are many remarkable things about living organisms. For one, they consist of billions of small units, cells, that work together in a harmonious way to produce a large entity. But perhaps even more remarkable, most of these cells do not survive for longer than a few days, even though the organism they create goes on to live for many years or decades. What that means is that a multi-cellular body is constantly undergoing change and renewal. The source of that renewal is a special kind of cell, called a stem cell. Most tissues in a living organism contain many stem cells, capable of renewing that tissue.
A stem cell is an undifferentiated cell, meaning it is not specialized to perform a particular function, like a skin cell or a muscle cell. Rather it retains embryonic-like qualities and can generate many different types of specialized or differentiated cells. The extent to which the cell is flexible depends on its state.
Reasons to Purchase
- Identify the 28 companies directly applying stem cell technology to therapeutics
- Understand the overall competitive landscape and the trends driving the stem cell market
- Examine the scientific, market and political hurdles impacting the success or failure of these companies
- Research the various technologies and therapeutic areas for applying stem cells
- Identify potential collaborative partners and/or investment opportunities
Target Audience
- Business development execs/managers seeking partnership opportunities
- Marketing and senior execs/managers wishing to understand the competitive landscape
- Research and development execs/managers wanting to know the current state-of-the-art
- Venture capitalists and fund managers seeking investments
- Analysts and journalists researching the emerging stem cell market
- Others seeking to understand the driving factors and market dynamics of stem cell research
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Stem Cell Markets
Stem Cell Research 2008
Global Stem Cell and Advanced Technologies Market
Stem Cell Research in Cardiology
Developments in Stem Cell Research
Stem Cell Appoaches in Neurology and Psychiatry
Opportunities in Human Embryonic Stem Cell (hESC) Products
The Stem Cell Report and Stem Cell Summit Webcast
Stem Cell Research Products: Opportunities, Tools & Technologies
US Stem Cell Market Analysis
Understanding Stem Cell Research
Stem Cells 2007-2008 Market Report
|
|
|
|
